Follow-up in a long-term randomized trial with neoadjuvant chemotherapy for squamous cell cervical carcinoma

European Journal of Gynaecological Oncology

Volumn 31, Issue 5, 2010, Pages 497-503

  Mossa, B ^a   Mossa, S ^b   Corosu, L ^a   Marziani, R ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAN CAMILLO FORLANINI HOSPITAL   (Italy)

Author keywords

Cervical cancer; Neoadjuvant chemotherapy; Radical hysterectomy

Indexed keywords

BLEOMYCIN; CISPLATIN; VINCRISTINE;

ADJUVANT CHEMOTHERAPY; ADULT; ADVANCED CANCER; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; HUMAN; HYSTERECTOMY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME; UTERINE CERVIX CARCINOMA;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYSTERECTOMY; MIDDLE AGED; NEOADJUVANT THERAPY; RADIOTHERAPY; UTERINE CERVICAL NEOPLASMS; VINCRISTINE;

EID: 78549239540     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Thomas G.M.: "Improved treatment of cervical cancer-concurrent chemotherapy and radiotherapy". N. Engl. J. Med., 1999, 340, 1198.
2. Burghardt E.: "Prognostic factors and operative treatment of Stages Ib to IIb cervical cancer". Am. J. Obstet. Gynecol., 1987, 156, 988.
3. Piver M.S., Chung W.S: "Prognostic significance of cervical lesion size and pelvic node metastases in cervical carcinoma". Obstet. and Gynecol., 1975, 46, 507.
4. Burke T.W., Hoskins W.J., Heller Pb., Bibro M.C., Weiser E.B., Park R.C: "Prognostic factors associated with radical hysterectomy failure". Gynecol. Oncol., 1987, 26, 153.
5. Sardi J., Sananes C., Giaroli A., Di Paola G., Maya G.: "Neoadjuvant chemotherapy in locally advanced carcinoma of the cervix uteri". Gynecol. Oncol.,1990, 38, 486.
6. Coleman R.E., Clarke J.M., Slevin M.L., Sweetenham J., Williams C.J., Blake P.: "A phase II study of ifosfamide and cisplatino chemotherapy for metastatic or relapsed carcinoma of cervix". Cancer Chemother. Pharmacol., 1990, 27, 52.
7. Sardi J., Sananes C., Giaroli A.: "Results of a prospective randomized trial with neodjuvant chemotherapy of the cervix". Gynecol. Oncol., 1993, 49, 156.
8. Eddy G.L., Manetta A., Alvarez R.D.: "Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO Stage IB bulky cervical cancer. Gynecologic Oncology Group pilot study". Gynecol. Oncol., 1995, 57, 412.
9. Keys H.M., Bundy B.N., Stheman F.B., Muderspach L.I., Chafe W.E., Suggs C.L. III et al.: "Cisplatin, radiation, and adjuvant hysterecttomy compared with radiation and adjuvant hysterectomy for bulky Stage IB cervical carcinoma". The New Engl. J. Med., 1999, 340, 1154.
10. Chang T.C., Lai C.H., Hsueh S.: "Randomized trial of neoadiuvant cisplatin, vincristine, bleomycin ad radical hysterectomy versus radiation therapy for bulky Ib and IIA cervical cancer". J. Clin. Oncol., 2000, 18, 1740.
11. Hwang Y.Y., Moon H., Cho S.H., Kim K.T., Moon Y.J., Kim S.R., Kim D.S.: "Ten-year survival patients with locally advanced, stage IB-IIB cervical cancer after neodjuvant chemotherapy and radical hysterectomy". Gynecol. Onco.l, 2001, 82, 88.
12. Benedetti Panici P.L., Greggi S., Colombo A., Amoroso M., Smamiotto D., Giannarelli D. et al.: "Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced cervical cancer: results from the Italian multicenter randomised study". J. Clin. Oncol., 2002, 20, 179.
13. DeSouza N.M., Souther W.P., Rustin G., Manon M.M., Joes B., Dina R., McIndoe G.A.: "Use of neoadjuvant chemotherapy prior to radical hysterectomy in cervical cancer: monitoring tumor shrinkage and molecular profile on magnetic resonance and assessment of 3-year outcome". Br. J. Cancer, 2004, 90, 2326.
14. Chen H., Liang C., Zhang L., Huang S., Wu X.: "Clinical efficacy of modified preoperative neoadjuvant chemotherapy in treatment of locally advanced (Stage Ib2 to IIB) cervical cancer: randomized study". Gynecol. Oncol., 2008, 110, 308.
15. Tattersall M., Ramirez C., Coppleson M.: "A randomized trial of adjuvant chemotherapy after radical hysterectomy in Stage Ib-IIa cervical cancer patients with pelvic lymph node metastasis". Gynecol. Oncol., 1992, 46, 176.
16. Kumar L., Kaushal R., Nandy M., Biswal B.M., Kumar S., Kriplani A. et al.: "Chemotherapy followed by radiotherapy versus radiotherapy alone in locally advanced cervical cancer: a randomized study". Ginecol. Oncol., 1994, 54, 307.
17. Tattersall M.N.H., Lorvidhaya V., Vootripux V.: "A randomized, trial of epirubicin cisplatin chemoterapy followed by pelvic radiation in locally in locally advanced cervical cancer patients with pelvic lymph node metastasis". J. Clin. Oncol., 1995, 13, 444.
18. Herod L., Burton A., Buxton J.A.: "A randomized, prospective, phase III clinical trial of primary bleomycin, ifosfamide and cisplatin (BIP) chemoterapy followed by radiationtherapy versus radiotherapy alone in inoperable cancer of the cervix". Ann. Oncol., 2000, 11, 1175.
19. Neoadjuvant Chemotherapy for Cervical Cancer Meta-analysis Collaboration: "Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials". Eur. J. Cancer, 2003, 39, 2470.
20. Petterson F.: "Annual report on the treatment in gynaecological cancer". Int. J. Obstet. Gynecol., 1991, 36, 27.
21. Sardi J., Sananes C., Giaroli A., Di Paola G., Maya G.: "Neodjuvant chemotherapy in cervical carcinoma Stage IIB: A randomized controlled trial". Int. J. Gynecol. Cancer, 1998, 8, 441.
22. Cai H.B., Chen H.Z., Yin H.H.: "Randomized study of preoperative chemotherapy versus primary surgery for Stage B cervical cancer". J. Obstet. Gynecol Res., 2006, 32, 315.
23. Eddy G.L., Bundy B.N., Creasman W.T., Spirtos N.M., Mannel R.S., Hannigan E., O'Connor D.: "Treatment of (bulky) Stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/paraortic lymphadenectomy: a phase III trial of the gynecologic oncology group". Gynecol. Oncol., 2007, 106, 362.
24. Sardi J.E., Boixadera M.A., Sardi J.J.: "Neodjuvant chemotherapy in cervical cancer". Curr. Opin. Obstet. Gynecol., 2005, 17, 43.
25. World Health Organization: "WHO Handbook for Reporting Results of Cancer Treatment. Geneva WHO Offset Publication". 1989, no. 48.
26. Piver M.S., Rutledge F., Smith J.P.: "Five classes of extended hysterectomy for women with cervical cancer". Obstet. Gynecol., 1974, 44, 265.
27. Napolitano C., Tocci B., Crosara B., Mogini C., Buzzi M., Marziani R.: "Management of invasive cervical carcinoma: our experience from 1961 to 1979". New Trends in Gynaec. and Obstet., 1986, 2, 139.
28. International Commission on Radiation Units and Measurement: "Dose and Volume Specification for reporting Intracavitary Therapy in Gynecology". Bethesda, MD, ICRU Report 38, 1985, 1.
29. Cox D.R.: "Regression models and life tables". J.R. Stat. Soc. (B) 1972, 34, 187.
30. Sardi J.E., Giaroli A., Sananes C., Ferreira M., Soderini A., Bermudez A. et al.: "Long-term follow-up of the first randomized trial using neoadiuvant chemotherapy in Stage Ib squamous carcinoma of the cervix: The final results". Gynecol. Oncol., 1997, 67, 61.
31. Napolitano C., Imperato F., Mossa B., Framarino M.L., Marziani R., Marzetti L.: "The role of neodjuvant chemoterapy for squamous cell cervical cancer (Ib-IIIb): a long-term randomized trial". Eur. J. Gynecol. Oncol., 2003, 24, 51.
32. Dottino P.R., Plaxe S.C., Beddoe A.M., Johnston C., Cohen C.J.: "Induction chemotherapy followed by radical surgery in cervical cancer". Gynecol. Oncol., 1991, 40, 7.
33. Mancuso S., Benedetti Panici P., Greggi S., Scambia G.: "Neoadiuvant chemotherapy in locally advanced cervical cancer". Contrib. Gynecol. Obstet., 1989, 17, 111.
34. Kim D.S., Moon H., Hwang Y.Y., Cho S.R.: "Two-year survival: preoperative adiuvant chemotherapy in the treatment of cervical cancer Stage Ib and II with bulky tumor". Gynecol. Oncol., 1989, 33, 225.
35. Bolis G., Van Zainten-Przybysz I., Scarfone G., Zanaboni F., Scartabelli C., Tateo S. et al.: "Determinants of response to a cisplatin-based regimen as neoadiuvant chemiotherapy in Stage Ib-IIb invasive cervical cancer". Gynecol. Oncol., 1996, 63, 62.
36. Katsumata N., Yoshikawa H., Hirakawa T., Saito T., Kuzuya K., Fujii T. et al.: "Phase III randomized trial of neoadjuvant chemotherapy followed by radical hysterectomy (RH) for bulky Stage I/II cervical cancer (JCOG 0102)". Proceeding of the American Society of Clinical Oncology, 2006, 24 (No 18S), abs. 5013.